首页> 外文OA文献 >Immunogene Therapy of Recurrent Glioblastoma Multiforme with a Liposomally Encapsulated Replication-Incompetent Semliki Forest Virus Vector Carrying the Human Interleukin-12 gene – a phase I/II Clinical Protocol

【2h】

Immunogene Therapy of Recurrent Glioblastoma Multiforme with a Liposomally Encapsulated Replication-Incompetent Semliki Forest Virus Vector Carrying the Human Interleukin-12 gene – a phase I/II Clinical Protocol

机译：携带人白细胞介素-12-12基因的脂质体包封的复兴 - 不称之不通的半碱病毒载体的逆转胶质母细胞瘤多形状的免疫基因治疗 - I / II临床方案

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
H. Ren; T. Boulikas; K. Lundstrom; A. Söling; P.C. Warnke; N.G. Rainov;
展开▼
作者单位

展开▼
年度 2003
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene--a phase I/II clinical protocol. [J] . Ren H, Boulikas T, Soling A, Journal of neuro-oncology. . 2003,第1a2期

机译：用携带人白介素12基因的脂质体封装的无复制能力的Semliki森林病毒载体对多形性成胶质细胞瘤进行免疫原性治疗-I / II期临床方案。
2. Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial. [J] . Prados MD, McDermott M, Chang SM, Journal of neuro-oncology. . 2003,第3期

机译：用单纯疱疹病毒胸苷激酶基因载体生产细胞治疗成人进行性或复发性多形性胶质母细胞瘤，然后静脉注射更昔洛韦：I / II期多机构试验。
3. Treatment of Progressive or Recurrent Glioblastoma Multiforme in Adults with Herpes Simplex Virus Thymidine Kinase Gene Vector-Producer Cells Followed by Intravenous Ganciclovir Administration: A Phase I/II Multi-Institutional Trial [J] . Michael D. Prados, Michael McDermott, Susan M. Chang, Journal of Neuro-Oncology . 2003,第3期

机译：单纯性疱疹病毒胸苷激酶基因载体生产细胞继发更昔洛韦静脉注射治疗成人多形性胶质母细胞瘤的进展或复发：I / II期多机构试验
4. Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol [O] . Karsten Geletneky, Johannes Huesing, Jean Rommelaere, 2012

机译：在患有进展性原发性或复发性多形性胶质母细胞瘤的患者中进行细小病毒H-1（ParvOryx）的肿瘤内/脑内或静脉内/脑内给药的I / IIa期研究：ParvOryx01方案
5. ET-21 * COMBINATION OF INTRAVENOUS AND INTRACEREBRAL INJECTION OF ONCOLYTIC PARVOVIRUS H-1 IN A PHASE I/IIA CLINICAL TRIAL OF PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME: PENETRATION OF H-1 VIRUS ACROSS THE BLOOD-BRAIN BARRIER [O] . K. Geletneky, A. Angelova, B. Leuchs, 2014

机译：ET-21 *静脉内和脑内注射溶血性Parvovirus H-1的组合在患有复发性胶质母细胞瘤患者的I / IIa临床试验中：H-1病毒对血脑屏障的渗透

Immunogene Therapy of Recurrent Glioblastoma Multiforme with a Liposomally Encapsulated Replication-Incompetent Semliki Forest Virus Vector Carrying the Human Interleukin-12 gene – a phase I/II Clinical Protocol

著录项

引文网络

相似文献

相关主题

期刊订阅